Published in BMJ on June 21, 1997
Disease modifying drugs in rheumatoid arthritis. BMJ (1997) 1.37
Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy. Br J Rheumatol (1989) 1.41
Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not? Rheumatology (Oxford) (2005) 1.38
Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology (Oxford) (2008) 1.17
Is methotrexate effective in ankylosing spondylitis? Rheumatology (Oxford) (2002) 1.10
Development, validation and use of a patient knowledge questionnaire (PKQ) for patients with early rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.03
Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis. Br J Rheumatol (1991) 0.95
Clearance of acanthosis nigricans associated with insulinoma following surgical resection. QJM (2008) 0.91
Focal myositis due to Campylobacter infection. Rheumatology (Oxford) (2001) 0.90
Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann Rheum Dis (2005) 0.82
Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin. Br J Rheumatol (1997) 0.78
Association between bronchiectasis and smoking in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 0.78
An outbreak of Salmonella agona infection associated with precooked turkey meat. Commun Dis Public Health (1998) 0.78
Fibromyalgia-monotheories, monotherapies and reductionism. Rheumatology (Oxford) (2001) 0.77
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1996) 0.75
Accuracy of history, examination, pulmonary function tests and chest radiographs in predicting high-resolution computed tomography-diagnosed interstitial lung disease. Br J Rheumatol (1997) 0.75
Infection and arthritis. Q J Med (1986) 0.75
Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol (1996) 0.75
Tc-DTPA clearance and rheumatoid arthritis-associated fibrosing alveolitis. Rheumatology (Oxford) (2002) 0.75
Methotrexate and penicillin interaction. Br J Rheumatol (1998) 0.75
Rheumatology telephone helpline services. Rheumatology (Oxford) (2002) 0.75
The importance of high-resolution computed tomography in the diagnosis of interstitial lung disease. Br J Rheumatol (1997) 0.75
Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford) (2004) 0.75
Outcome measures for rheumatologists. Rheumatology (Oxford) (2003) 0.75
Infections and anti-TNF therapy: strategies for screening based on clinical experience. Rheumatology (Oxford) (2004) 0.75
Advice to car drivers with rheumatoid arthritis. Br J Rheumatol (1995) 0.75